Media Contact:
Nalini Padmanabhan
ASHG Communications Manager
301.634.7346
press@ashg.org
For Immediate Release
Tuesday, October 18, 2016
6:00 p.m. U.S. Pacific Time
Findings Reported at ASHG 2016 Annual Meeting
BETHESDA, MD – In a large-scale, genome-wide analysis of more than 110,000 samples, a worldwide consortium of scientists has identified 200 genetic loci associated with multiple sclerosis (MS), an inflammatory and neurodegenerative disease in which a person’s immune system attacks the brain and spine, disrupting signaling between the brain and the body. Their findings were presented in a featured plenary session at the American Society of Human Genetics (ASHG) 2016 Annual Meeting in Vancouver, B.C.
Established in 2003, the International Multiple Sclerosis Genetics Consortium (IMSGC) brings together researchers from 30 institutions in 18 countries that study the genetics of MS. By combining data from multiple genome-wide association studies, the consortium assembled genomic data from 47,351 people diagnosed with MS and 68,284 without the condition.
“This is the largest study of this disease worldwide,” said Nikolaos A. Patsopoulos, MD, PhD, a principal investigator in the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital (BWH), assistant professor of Neurology at Harvard Medical School, and associate member at the Broad Institute, who presented the research on behalf of the IMSGC. “The large sample size provided the statistical power to pinpoint areas of the genome that are likely to be involved in MS, including less common genetic variants that tend to have a larger effect on disease.”
By comparing the genomes of people with and without MS, the researchers identified 200 variants that were significantly more common among those with the disease. Most of these variants implicate genes that are associated with immune cells and immune system function, including a few potentially specific to brain-related functions.
“This confirms the complex interplay of different elements of the immune system in MS susceptibility and highlights the role of several different immune cells that contribute to the initiation of this inflammatory disease,” explained Phil De Jager, MD, PhD, senior author of the study, director of the Program in Translational NeuroPsychiatric Genomics at the Ann Romney Center for Neurologic Diseases, an associate professor of Neurology at Harvard Medical School, and an associate member at the Broad Institute. “While we now have some hints, the mechanisms that lead this inflammatory disease to target the brain and spinal cord remain unclear,” he added.
Interestingly, many of the genes identified were known to also be involved in other autoimmune diseases, such as rheumatoid arthritis, Type I diabetes, and ulcerative colitis. This raises intriguing questions about why these diseases target different organs and have different clinical manifestations.
“The differences and commonalities between MS and other autoimmune diseases are part of our line of research,” Dr. Patsopoulos said. “Many of these conditions affect immune system cells, but we believe they change these cells in different ways, leading to different disease outcomes.”
This study highlights the power of collaboration, the study authors noted. “None of us could have completed this work on our own,” explained Adrian Ivinson, PhD, IMSGC coordinator and executive director of the BWH Institute for the Neurosciences. “Only by sharing our energy and resources have we been able to produce this detailed genetic map of multiple sclerosis and to share this invaluable data with the rest of the MS research community. Using the same approach, the IMSGC now hopes to turn its attention to the genetic underpinnings of progressive multiple sclerosis, the most aggressive form of MS,” added Dr. Ivinson.
This study was supported by many MS research organizations, private donors, and multiple grants. Dr. Patsopoulos was partly funded with a Career Independence Award by the National MS Society to complete this study.
Presentation: Dr. Patsopoulos will present his research on Tuesday, October 18, 2016, from 6:00-6:20 p.m., in Ballroom ABC of the Vancouver Convention Centre, West Building.
Press Availability: Dr. Patsopoulos will be available to discuss this research with interested media on Thursday, October 20, 2016, from 11:30 a.m.-12:15 p.m. in the ASHG 2016 Press Office (Room 111).
Reference: Patsopoulos N, on behalf of IMSGC. (2016 Oct 18). Abstract: 200 loci complete the genetic puzzle of multiple sclerosis. Presented at the American Society of Human Genetics 2016 Annual Meeting. Vancouver, B.C., Canada.
About the American Society of Human Genetics (ASHG)
Founded in 1948, the American Society of Human Genetics is the primary professional membership organization for human genetics specialists worldwide. Its nearly 8,000 members include researchers, academicians, clinicians, laboratory practice professionals, genetic counselors, nurses, and others with an interest in human genetics. The Society serves scientists, health professionals, and the public by providing forums to: (1) share research results through the ASHG Annual Meeting and in The American Journal of Human Genetics; (2) advance genetic research by advocating for research support; (3) educate current and future genetics professionals, health care providers, advocates, policymakers, educators, students, and the public about all aspects of human genetics; and (4) promote genetic services and support responsible social and scientific policies. For more information, visit: http://www.ashg.org.
9650 Rockville Pike | Bethesda, MD 20814 | 301.634.7300 | society@ashg.org | www.ashg.org
Connect with ASHG on Twitter (@GeneticsSociety) | Facebook | LinkedIn